Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients
Status:
Completed
Trial end date:
2013-05-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the preventive efficacy for HSV infection and safety
of valaciclovir (VACV) in the adult and pediatric HSCT patients.